Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ALS surrogate markers. MUNE.

C L Gooch1, J M Shefner

  • 1Columbia College of Physicians and Surgeons, Columbia Presbyterian Medical Center, New York, NY 10032, USA. clg33@columbia.edu

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).

European journal of neurology·2018
Same author

Multipoint incremental motor unit number estimation as an outcome measure in ALS.

Neurology·2011
Same author

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.

Neurology·2007
Same author

Revised statistical motor unit number estimation in the Celecoxib/ALS trial.

Muscle & nerve·2006
Same author

Lead exposure as a risk factor for amyotrophic lateral sclerosis.

Neuro-degenerative diseases·2006
Same author

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.

Neurology·2006
Same journal

Dementia of frontal lobe type in Kennedy's disease.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2005
Same journal

Venous thrombosis in an ALS population over four years.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2005
Same journal

Spirometer-dependence of vital capacity in ALS: validation of a portable device in 52 patients.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2005
Same journal

A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2005
Same journal

Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2005
Same journal

Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2005
See all related articles

Motor unit number estimation (MUNE) quantifies motor unit loss in amyotrophic lateral sclerosis, aiding therapy assessment and tracking disease progression. MUNE is a valuable tool for motor neuron disease research.

Area of Science:

  • Neuroscience
  • Neurology

Background:

  • Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor unit loss.
  • Motor unit number estimation (MUNE) is increasingly utilized in ALS research.

Purpose of the Study:

  • To highlight the utility of MUNE in quantifying motor unit loss in ALS.
  • To discuss MUNE's role in assessing therapeutic interventions and tracking disease progression.
  • To emphasize MUNE's potential as an early biomarker in clinical trials.

Main Methods:

  • MUNE methods enable quantitative assessment of motor unit numbers.
  • MUNE can simultaneously evaluate collateral reinnervation.
  • Application in animal models and human patients.

Main Results:

Related Experiment Videos

  • Studies show an average 50% motor unit loss every six months in ALS progression.
  • MUNE provides insights into motor unit behavior during anterior horn cell degeneration.
  • MUNE incorporation into clinical trials shows promising results as a biomarker.

Conclusions:

  • MUNE is an effective tool for studying motor neuron diseases like ALS.
  • Refined MUNE methods are crucial for advancing motor neuron disease research.
  • MUNE aids in evaluating neuroprotective and reinnervation-enhancing therapies.